These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 9818602
1. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Kroll S, Char DH, Quivey J, Castro J. Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602 [Abstract] [Full Text] [Related]
2. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S. Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [Abstract] [Full Text] [Related]
3. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P. Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [Abstract] [Full Text] [Related]
4. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF. Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942 [Abstract] [Full Text] [Related]
5. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T. Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534 [Abstract] [Full Text] [Related]
6. Survival after proton-beam irradiation of uveal melanomas. Kodjikian L, Roy P, Rouberol F, Garweg JG, Chauvel P, Manon L, Jean-Louis B, Little RE, Sasco AJ, Grange JD. Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783 [Abstract] [Full Text] [Related]
7. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Isager P, Ehlers N, Overgaard J. Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846 [Abstract] [Full Text] [Related]
8. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD. Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155 [Abstract] [Full Text] [Related]
9. Long-term follow-up after uveal melanoma charged particle therapy. Char DH, Kroll SM, Castro J. Trans Am Ophthalmol Soc; 1997 May; 95():171-87; discussion 187-91. PubMed ID: 9440169 [Abstract] [Full Text] [Related]
10. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P, Kivelä T. Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [Abstract] [Full Text] [Related]
12. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L, Tarkkanen A. Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359 [Abstract] [Full Text] [Related]
13. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Augsburger JJ, Corrêa ZM, Freire J, Brady LW. Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176 [Abstract] [Full Text] [Related]
14. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Coupland SE, Campbell I, Damato B. Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722 [Abstract] [Full Text] [Related]
15. Metastatic melanoma in the eye and orbit. Zografos L, Ducrey N, Beati D, Schalenbourg A, Spahn B, Balmer A, Othenin-Girard CB, Chamot L, Egger E. Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536 [Abstract] [Full Text] [Related]
16. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Trans Am Ophthalmol Soc; 2002 Nov; 100():43-8; discussion 48-9. PubMed ID: 12545676 [Abstract] [Full Text] [Related]
17. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas. Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe'er J. Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767 [Abstract] [Full Text] [Related]
18. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Scheibenbogen C, Thiel E, Foerster MH, Keilholz U. Clin Cancer Res; 2007 Feb 15; 13(4):1171-8. PubMed ID: 17317826 [Abstract] [Full Text] [Related]
19. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, Meyer A, Nauraye C, Mazal A, Mammar H, Garcia P, D'Hermies F, Frau E, Plancher C, Asselain B, Schlienger P, Mazeron JJ, Desjardins L. Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):780-7. PubMed ID: 16647221 [Abstract] [Full Text] [Related]
20. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience. Caujolle JP, Mammar H, Chamorey E, Pinon F, Herault J, Gastaud P. Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):98-103. PubMed ID: 19910136 [Abstract] [Full Text] [Related] Page: [Next] [New Search]